Navigation Links
Researchers Report Treatment Headway Against Lung Cancer
Date:6/5/2010

fects eased over time, Bang said.

The fusion gene was first discovered to play a role in this type of lung cancer in 2007. Researchers are now working on a phase 3 trial of the drug. The Korean researchers reported financial ties to Pfizer.

The second study, a phase 3 trial, involved 451 patients with advanced non-small cell lung cancer aged 70 to 89. The study had first expected to enroll 520 patients, but it was halted early when good survival results were seen in the group taking the combination therapy.

Currently, elderly patients are typically given just one chemotherapy drug, with younger patients more likely to get two or more.

In this trial, participants were randomly selected to receive either one chemotherapy agent -- gemcitabine (Gemzar) or vinorelbine (Navelbine) -- or to receive both carboplatin and paclitaxel (Taxol).

For the single-agent group, median survival at one year was 6.2 months and 27 percent patients were still alive, "which is consistent with previous research," said study author Dr. Elisabeth Quoix, a professor of medicine at University Hospital in Strasbourg, France.

"In the double-therapy group, the median survival increased by four months [to 10.3 months], which is quite unusual in thoracic oncology," Quoix said. "Forty-five percent of patients survived one year, which is also quite unusual."

"The four-month improvement is a huge one," added Kris, who is chief of thoracic oncology at Memorial Sloan-Kettering Cancer Center in New York City. "Other large clinical trials ... have generally felt to be practice-changing with a two-month change in median survival. This trial supports the idea that patients over 70 should be treated just as anyone else."

Quoix and other study authors reported ties with different pharmaceutical companies, including Eli Lilly Co. and Roche Inc.

Finally, a phase 3 study out of the University of Texas M.D. Anderson Cancer C
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MSU researchers discover potential genetic factor in eating disorders
2. Mount Sinai researchers approaching universal treatment for all strains of influenza
3. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
4. Basque researchers apply chemistry to restoration of paintings and dating of signatures
5. Researchers offer solutions to poisonous well-water crisis in southern Asia
6. Researchers report no difference in breast cancer characteristics after oophorectomy
7. Vanderbilt researchers play major role in new center on electronic health information privacy
8. Pitt researchers discover gene mutation linked to lymphatic dysfunction
9. Researchers validate a new test for assessing childrens and teenagers fitness to prevent morbidity
10. Novel anti-malarial drug candidate found by UT Southwestern researchers
11. Mount Sinai researchers move closer to a universal influenza vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... New York (PRWEB) March 04, 2015 ... reviewing the cardiovascular risks potentially associated with low testosterone ... Administration (FDA) announced that it will now require manufacturers ... increase their risk for heart attacks and strokes. In ... 2015, the agency also stated that it was requiring ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 " Optrix ... part of its monthly Tech Report, which takes a ... services available to consumers. Scott Steinberg, a special reporter ... review and shared with viewers how they have an ... The mobile industry is a major player at the ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The popular ... of their new L-Style Revolution™ Program. The customized program ... and women of all health and fitness levels to ... goals faster than traditional methods. , “We’re really proud ... customized plans based on award winning techniques to help ...
(Date:3/4/2015)... Information Innovators Inc . (Triple-i) is honored ... the company as Chief Technology Officer. Mr. Dvorak will ... company, including customer-centric strategies and initiatives, and promoting continuous ... as a technology executive and visionary. Prior to joining ... including oversight of enterprise data management, analytic software development, ...
(Date:3/4/2015)... In a small ceremony with 20 attendees ... new facility in New Port Richey on February 24, 2015 ... will allow the Florida drug detox facility to ... epidemic through treatment and education. “Due to our unique medical-detox ... United States, we made the decision that expanding our facility ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:The Makers of Liporidex, The Popular Sports Nutrition Supplement Brand, Launches Its New L-Style Revolution™ Diet & Exercise Program That Promises Turbo Charged Results 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3
... cardiovascular diseaseHOUSTON, Feb. 5 "I salute American Heart ... killer - cardiovascular diseases, including stroke. As a ... a clinical scientist and flight surgeon, I can attest ... and health care fields -- notably through the space ...
... SAN FRANCISCO, Calif., Feb. 5 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... Gower, the,company,s chairman and chief executive officer, is scheduled ... CEO & Investor Conference in New York,City on Monday, ... To access the live audio webcast or ...
... CHICAGO, Feb. 5 In recent years, Electronic Health ... as a means of improving patient care and controlling ... lower than expected due to general resistance related to ... studies have shown, however, that many of these adoption ...
... largest publisher of print guides to job boards, announced ... Health Care, the largest niche job board for USA ... this prestigious award for the third year in a ... multi-billion dollar global online employment services industry where actual ...
... billed as the world,s first hot pepper nasal spray when it was launched ... Allergy Buster are moving onto the shelves of more than 5,000 Rite Aid ... ... Sinus Buster as the world,s first hot pepper nasal spray in 2004 ...
... Networks, Inc. has announced that it has sold the rights to ... history tracking service, to nOOkist™. , ... New York, ... ), the company behind the popular MyBlackBook.Org service, has announced that ...
Cached Medicine News:Health News:Coalition for Space Exploration Salutes American Heart Month 2Health News:How to Select an Electronic Health Record System That Healthcare Professionals Can Use 2Health News:For the Third Year in a Row, Absolutely Health Care is Awarded a WEDDLE's User's Choice Award 2Health News:For the Third Year in a Row, Absolutely Health Care is Awarded a WEDDLE's User's Choice Award 3Health News:Sinus Buster Pepper Nasal Spray Moves Into Rite Aid Drug Stores 2Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 2Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 3
(Date:3/4/2015)... -- GSI Group Inc. (NASDAQ: GSIG ) ... supplier of precision photonics and motion control components and ... markets, today reported financial results for the fourth quarter ... results in this press release are GAAP measures from ... quarter of 2014, GSI generated revenue of $94.0 million, ...
(Date:3/4/2015)...  Nevro Corp. (NYSE: NVRO ), a ... innovative, evidence-based neuromodulation platform for the treatment of chronic ... for the fourth quarter  and full year of 2014 ... management will host a conference call beginning at 1:30 ... March 18, 2015. Individuals interested in ...
(Date:3/4/2015)... The March 3, 2015, order from the Federal Drug Administration ... labels to clarify the drugs, intended use and warn about ... to protect the public from injury from these products, according ... Hanly Conroy . The order says that the ... currently taken by millions of U.S. men – are approved ...
Breaking Medicine Technology:GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 16GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 17GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 18GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 19GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 20GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 21GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 23GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 24GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 25GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 26GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 27GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 28GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 29GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 30GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 31GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 32GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 33Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2
... SCOTTSDALE, Ariz., Feb. 15, 2011 Cayenne Medical, Inc., ... of AperFix® II, its second generation soft tissue repair ... was made today at the 2011 American Academy of ...   Key to AperFix II is the ...
... Baxano, Inc. ( w w w.b a ... today announced the addition of George A. Harter, Jr. to the ... will be responsible for Finance, Administration and Human Resources. ... from 2005 to 2011, through its acquisition by Johnson & Johnson. ...
Cached Medicine Technology:Cayenne Medical, Inc. Launches AperFix® II 2Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer 2
... in 1937 with the Aviator style created ... Luxottica Group's brand portfolio in 1999. Worn ... since day one, Ray-Bans styles are sunglasses ... sunglasses in the world. Characterized by high ...
... manufacturing the Anne Klein brand under license ... are designed for an all-female market. The ... eyewear identifies herself with the typical modern ... who is image-conscious and quality-conscious and loves ...
... in mind, making eyewear that is kid-tough ... Its not surprising that Disney eyewear was ... selling childrens collection from 1997-2003. Part of ... ability to keep pace with todays fashion ...
... frame mounting technology has redefined rimless collections ... taper at the end of each frame ... of the bushing that mounts within the ... a secure fit is created that far ...
Medicine Products: